New Delhi metallo-β-lactamase-producing carbapenem-resistant escherichia coli associated with exposure to duodenoscopes

JAMA - Journal of the American Medical Association

Volumn 312, Issue 14, 2014, Pages 1447-1455

  Epstein, Lauren ^a,b   Hunter, Jennifer C ^a,b   Arwady, M Allison ^b,c   Tsai, Victoria ^c   Stein, Linda ^d   Gribogiannis, Marguerite ^d   Frias, Mabel ^e   Guh, Alice Y ^a   Laufer, Alison S ^a   Black, Stephanie ^f   Pacilli, Massimo ^f   Moulton Meissner, Heather ^a   Rasheed, J Kamile ^a   Avillan, Johannetsy J ^a   Kitchel, Brandon ^a   Limbago, Brandi M ^a   MacCannell, Duncan ^a   Lonsway, David ^a   Noble Wang, Judith ^a   Conway, Judith ^c   Conover, Craig ^c   Vernon, Michael ^e   Kallen, Alexander J ^a   more..

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

^d ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^e Cook County Department of Public Health ^*  (United States)

^f CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE OXIDE; METALLO BETA LACTAMASE; PHTHALALDEHYDE; BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT ESCHERICHIA COLI; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISINFECTION; DUODENOSCOPE; FEMALE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INSTRUMENT STERILIZATION; MALE; MIDDLE AGED; POPULATION EXPOSURE; UNITED STATES; VERY ELDERLY; ANTIBIOTIC RESISTANCE; COHORT ANALYSIS; CROSS INFECTION; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EPIDEMIC; EQUIPMENT CONTAMINATION; ESCHERICHIA COLI; HOSPITAL; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DISINFECTION; DRUG RESISTANCE, BACTERIAL; DUODENOSCOPES; ENTEROBACTERIACEAE INFECTIONS; EQUIPMENT CONTAMINATION; ESCHERICHIA COLI; FEMALE; HOSPITALS; HUMANS; ILLINOIS; MALE; MIDDLE AGED;

EID: 84907690490     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.12720     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62(9):165-170.
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2011;53(1):60-67.
3. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2011;53(6):532-540.
4. Centers for Disease Control and Prevention. Notes from the field: New Delhi metallo-β- lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography-Illinois, 2013. MMWR Morb Mortal Wkly Rep. 2014;62(51-52):1051.
5. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50(12):3877-3880.
6. Bond WW. S. S. Microbiologic assay of environmental and medical device surfaces. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook. 2nd ed.Washington, DC: American Society for Microbiology Press; 2004.
7. Miner N, Harris V, Ebron T, Cao TD. Sporicidal activity of disinfectants as one possible cause for bacteria in patient-ready endoscopes. Gastroenterol Nurs. 2007;30(4):285-290.
8. Centers for Disease Control and Prevention. Multiplex real-time PCR detection of Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes. http://www.cdc.gov/HAI/settings/lab/kpc-ndm1-lab-protocol.html. Accessed September 2, 2014.
9. Centers for Disease Control and Prevention. Standard operating procedure for PulseNet PFGE of Escherichia coli O157:H7, Escherichia coli non-O157 (STEC), Salmonella serotypes, Shigella sonnei, and Shigella flexneri. http://www.cdc.gov/pulsenet/PDF/ecoli-shigella-salmonella-pfge-protocol-508c.pdf. Accessed September 2, 2014.
10. Hennekinne JA, Kerouanton A, Brisabois A, De Buyser ML. Discrimination of Staphylococcus aureus biotypes by pulsed-field gel electrophoresis of DNA macro-restriction fragments. J Appl Microbiol. 2003;94(2):321-329.
11. US Food and Drug Administration. FDA-cleared sterilants and high-level disinfectants with general claims for processing reusable medical and dental devices-March 2009. http://www.fda.gov/medicaldevices/deviceregulationandguidance/reprocessingofsingle-usedevices/ucm133514.htm Accessed September 2, 2014.
12. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis. J Clin Microbiol. 1995;33(9):2233-2239.
13. Alfa MJ. Monitoring and improving the effectiveness of cleaning medical and surgical devices. AmJ Infect Control. 2013;41(5)(suppl):S56- S59.
14. Aumeran C, Poincloux L, Souweine B, et al. Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography. Endoscopy. 2010;42(11):895-899.
15. Carbonne A, Thiolet JM, Fournier S, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. http://www.eurosurveillance.org/images/dynamic/EE/V15N48/art19734.pdf. Accessed September 2, 2014.
16. Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 1982;27(2):169-170.
17. Fraser TG, Reiner S, Malczynski M, Yarnold PR, Warren J, Noskin GA. Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography. Infect Control Hosp Epidemiol. 2004;25(10):856-859.
18. Gastmeier P, Vonberg RP. Klebsiella spp. in endoscopy-associated infections. Infection. 2014; 42(1):15-21.
19. Kovaleva J, Meessen NE, Peters FT, et al. Is bacteriologic surveillance in endoscope reprocessing stringent enough? Endoscopy. 2009; 41(10):913-916.
20. Low DE, Micflikier AB, Kennedy JK, Stiver HG. Infectious complications of endoscopic retrograde cholangiopancreatography. Arch Intern Med. 1980; 140(8):1076-1077.
21. Muscarella LF. Investigation and prevention of infectious outbreaks during endoscopic retrograde cholangiopancreatography. Endoscopy. 2010;42 (11):957-959.
22. Nelson DB. Infection control during gastrointestinal endoscopy. J Lab Clin Med. 2003; 141(3):159-167.
23. Ofstead CL, Wetzler HP, Snyder AK, Horton RA. Endoscope reprocessing methods. Gastroenterol Nurs. 2010;33(4):304-311.
24. Struelens MJ, Rost F, Deplano A, et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy. Am J Med. 1993;95(5):489-498.
25. Thornhill G, Bommarito M, Morse DJ. Monitoring the manual cleaning of flexible endoscopes with an ATP detection system. Am J Infect Control. 2012;40:e184-e5.
26. Petersen BT, Chennat J, Cohen J, et al. Multi society guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc. 2011;73(6):1075-1084.
27. Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. http://www.cdc.gov/hicpac/pdf/guidelines/disinfection-nov-2008.pdf. Accessed September 2, 2014.
28. Taylor A, Jones D, Everts R, Cowen A, Wardle E. Infection control in endoscopy. http://www.gesa.org.au/files/editor-upload/File/DocumentLibrary/Professional/Infection-Control-in-Endoscopy-Guidelines-2014.pdf. Accessed September 2, 2014.
29. Beilenhoff U, Neumann CS, Rey JF, Biering H, Blum R, Schmidt V; ESGE Guidelines Committee. ESGE-ESGENA guideline for quality assurance in reprocessing. Endoscopy. 2007;39(2):175-181.
30. Alfa MJ, Fatima I, Olson N. The adenosine triphosphate test is a rapid and reliable audit tool to assess manual cleaning adequacy of flexible endoscope channels. Am J Infect Control. 2013;41 (3):249-253.
31. Bommarito M, Thornhill GA, Morse DJ. A multisite field study evaluating the effectiveness of manual cleaning of flexible endoscopes with an ATP detection system. Am J Infect Control. 2013;41:S24.
32. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57(9):1246-1252.
33. Centers for Disease Control and Prevention. 2012 CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). http://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Accessed September 3, 2014.
34. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30(12):1180-1185.
35. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028-1033.
36. Swaminathan M, Sharma S, Poliansky Blash S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013;34(8):809-817.